Lappe Markinsider trades
In SEC Form 4 filings, Lappe Mark is listed as Chief Executive Officer of Inhibrx Biosciences, Inc. (INBX). In the last 90 days, Lappe Mark bought $4.49M of Inhibrx Biosciences, Inc. (INBX) on the open market and sold none. The largest purchase was $1.09M of Inhibrx Biosciences, Inc. (INBX) on Sep 8. Took part in a cluster buy; the latest at Inhibrx Biosciences, Inc. (INBX), where 2 insiders bought within 13 days, ending Sep 28.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| INBXInhibrx Biosciences, Inc. | Chief Executive Officer | 16 | Oct 14 |
Cluster buys
- INBX: 2 insiders bought $2.00M between Sep 16 – Sep 28.
Form 4 historysince 2026-09-08
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| INBXInhibrx Biosciences, Inc. | Oct 14 | Oct 14 | P | 2,470 | $84.07 | Purchase +$207,655 | 743,018 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Oct 14 | Oct 14 | P | 2,470 | $85.00 | Purchase +$209,948 | 745,488 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Oct 14 | Oct 14 | P | 100 | $85.76 | Purchase +$8,576 | 745,588 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Oct 14 | Oct 14 | P | 2,449 | $84.07 | Purchase +$205,889 | 167,449 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Oct 14 | Oct 14 | P | 2,451 | $85.00 | Purchase +$208,333 | 169,900 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Oct 14 | Oct 14 | P | 100 | $85.76 | Purchase +$8,576 | 170,000 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 28 | Sep 28 | P | 1,500 | $98.88 | Purchase +$148,320 | 737,548 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 28 | Sep 28 | P | 3,000 | $101.70 | Purchase +$305,106 | 740,548 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 25 | Sep 28 | P | 3,324 | $98.87 | Purchase +$328,630 | 733,872 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 25 | Sep 28 | P | 2,176 | $99.60 | Purchase +$216,727 | 736,048 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 8 | Sep 8 | P | 5,895 | $99.29 | Purchase +$585,343 | 711,443 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 8 | Sep 8 | P | 6,605 | $100.64 | Purchase +$664,719 | 718,048 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 8 | Sep 8 | P | 1,100 | $107.12 | Purchase +$117,836 | 719,148 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 8 | Sep 8 | P | 500 | $108.24 | Purchase +$54,118 | 719,648 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 8 | Sep 8 | P | 1,219 | $111.88 | Purchase +$136,382 | 720,867 | No | Form 4 |
| INBXInhibrx Biosciences, Inc. | Sep 8 | Sep 8 | P | 9,681 | $112.28 | Purchase +$1,087,001 | 730,548 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.